Literature DB >> 7336969

Preliminary studies on the absorption, distribution, metabolism, and excretion of THIP in animal and man using 14C-labelled compound.

B Schultz, T Aaes-Jørgensen, K P Bøgesø, A Jørgensen.   

Abstract

Distribution of radioactivity in rats, serum levels in human volunteers and rats and elimination of radioactivity in volunteers, rats, and mice following oral administration of 14C-labelled THIP have been investigated. Peak values of radioactivity in the organs and in serum were seen half an hour after administration, indicating a rapid absorption. Highest concentrations of radioactivity were found in the kidneys, but radioactivity was seen in all investigated tissues including the brain. The radioactivity was mainly excreted with urine (84-93%). Thin-layer chromatography of urine from volunteers, rats, and mice showed that most of the excreted radioactivity corresponds to unchanged THIP. Three metabolites were found in urine from rats each in amounts of 2-7% of total dose given. Two of these metabolites were also found in urine from the volunteers in amounts of 30-35% and greater than 2%, respectively, and in urine from mice in amounts of 21% and 6% of the total dose, respectively. No radioactivity corresponding to unchanged THIP was found in faeces indicating complete absorption of THIP following oral administration. One of the metabolites, the main one in man and mouse, seemed to be glucuronic acid conjugate of THiP, but the chemical structure of the metabolites has not yet been established.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7336969     DOI: 10.1111/j.1600-0773.1981.tb00879.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  8 in total

1.  Sleep-stabilizing effects of E-6199, compared to zopiclone, zolpidem and THIP in mice.

Authors:  Chloé Alexandre; Alberto Dordal; Ramon Aixendri; Antonio Guzman; Michel Hamon; Joëlle Adrien
Journal:  Sleep       Date:  2008-02       Impact factor: 5.849

2.  The analgesic effect of the GABA-agonist THIP in patients with chronic pain of malignant origin. A phase-1-2 study.

Authors:  M Kjaer; H Nielsen
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

3.  Intestinal gaboxadol absorption via PAT1 (SLC36A1): modified absorption in vivo following co-administration of L-tryptophan.

Authors:  M Larsen; R Holm; K G Jensen; B Brodin; C U Nielsen
Journal:  Br J Pharmacol       Date:  2009-07-07       Impact factor: 8.739

4.  Estradiol and testosterone modulate the anesthetic action of the GABA-A agonist THIP, but not of the neurosteroid 3alpha,5beta-pregnanolone in the rat.

Authors:  Oscar González-Flores; Norma Sánchez; Marcos García-Juárez; Francisco Javier Lima-Hernández; Gabriela González-Mariscal; Carlos Beyer
Journal:  Psychopharmacology (Berl)       Date:  2003-12-17       Impact factor: 4.530

5.  Metabolism and renal elimination of gaboxadol in humans: role of UDP-glucuronosyltransferases and transporters.

Authors:  Xiao-Yan Chu; Yuexia Liang; Xiaoxin Cai; Karla Cuevas-Licea; Ronda K Rippley; Kelem Kassahun; Magang Shou; Matthew P Braun; George A Doss; M Reza Anari; Raymond Evers
Journal:  Pharm Res       Date:  2008-12-11       Impact factor: 4.200

6.  Effects of early-life exposure to THIP on phenotype development in a mouse model of Rett syndrome.

Authors:  Weiwei Zhong; Christopher Mychal Johnson; Yang Wu; Ningren Cui; Hao Xing; Shuang Zhang; Chun Jiang
Journal:  J Neurodev Disord       Date:  2016-10-19       Impact factor: 4.025

7.  Conditioned Aversion and Neuroplasticity Induced by a Superagonist of Extrasynaptic GABAA Receptors: Correlation With Activation of the Oval BNST Neurons and CRF Mechanisms.

Authors:  Elena de Miguel; Olga Vekovischeva; Lauri V Elsilä; Anne Panhelainen; Esko Kankuri; Teemu Aitta-Aho; Esa R Korpi
Journal:  Front Mol Neurosci       Date:  2019-05-24       Impact factor: 5.639

8.  Acutely increasing δGABA(A) receptor activity impairs memory and inhibits synaptic plasticity in the hippocampus.

Authors:  Paul D Whissell; Dave Eng; Irene Lecker; Loren J Martin; Dian-Shi Wang; Beverley A Orser
Journal:  Front Neural Circuits       Date:  2013-09-17       Impact factor: 3.492

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.